The study developed a risk scoring model to predict death from cirrhosis and hepatorenal syndrome, helping identify high-risk patients for early intervention.
The model was based on data from 196 patients and included factors like liver cancer and specific biochemical markers.
It effectively distinguished between lower and higher mortality risk groups, indicating its utility in clinical settings for managing patient care.